Ectopic breast tissues may be affected by to the same physiological and pathological alterations seen in the normal breast, including fi broadenoma. We report a 30-year-old nulliparous woman who presented with a left axillary lump, for which clinical impression of axillary lymphadenopathy was made. She was receiving treatment with cabergoline due to a prolactinoma with galactorrhea for some years, but her serum prolactin levels were still high. The patient underwent surgical resection of the nodule and the histology was identical to the fi broadenomas seen in the breast. To the best of our knowledge, this is the fi rst report of fi broadenoma of the axilla in a patient with a macroprolactinoma. fi broadenoma in an ectopic breast tissue must be kept in mind in the differential diagnosis of axillary mass.

Strychnine acts as an inhibitor of post-synaptic neuronal inhibition and intoxication leads to distinct clinical manifestations which may culminate in death. Since its commercialization is prohibited in most countries, cases of strychnine intoxication are now rare. We present a case of an elderly patient who voluntarily ingested a white powder thought to be strychnine. He developed myoclonus, startle response, and episodes of generalized muscle contractions accompanied by respiratory arrest in one occasion. Diazepam, valproic acid and supportive treatments were able to control manifestations, however the patient died after 2 days. Our aim is to alert clinicians that, despite its rarity, strychnine intoxication may still be seen in emergency departments, and clinical outcome can be influenced by rapid recognition and timely institution of adequate treatment.